PATENT CLAIM ANALYSIS

Application Number: 15746806
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to the combination of a PARP inhibitor with a Dbait molecule for treating cancer.

Claim (Index 11):
The method according to  claim 2 , wherein the cancer is selected from leukemia, lymphoma, sarcoma, melanoma, and cancers of the head and neck, kidney, ovary, pancreas, prostate, thyroid, lung, esophagus, breast, bladder, brain, colorectum, liver, and cervix.

Metadata:
- Claim Count in Document: 67.0
- Percentile: 86.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13703965', '14118583', '15632951', '15232844', '14923482']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8460250186095297
- 35 USC 102 Novelty (BERT): 0.5746596933437589
- Combined Prediction Score: 0.8188884860829526
- Mean Citation Score: 480.07088600000014
- Max Citation Score: 505.55835
- Similarity Product: 378.4826198390544

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test